Kiromic Biopharma, Inc.
KRBPDelisted Nov 20, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001792581
Kiromic Biopharma, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Aug 26, 2024; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Kiromic Biopharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Kiromic Biopharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bersani Pietro | Chief Executive Officer | 142,333 | Aug 26, 2024 | 0 |
| Hungerford Brian | Chief Financial Officer | 64,933 | Aug 21, 2024 | 0 |
| Misajon Pamela | Director | 28,811 | Jun 13, 2024 | 0 |
| Nagel Michael | Director | 43,296 | Jun 12, 2024 | 0 |
| Ralston Shannon | 10% Owner | – | Jun 4, 2024 | 0 |
| Catlin Michael | Director | 25,500 | Mar 20, 2024 | 0 |
| Dahlbeck Scott | Chief of Staff | 496,757 | Aug 15, 2022 | 0 |
| Clark Daniel Grant | Chief Financial Officer | 62,770 | Aug 15, 2022 | 0 |
| Cicchetti Americo | Director | – | Jul 5, 2022 | 0 |
| Tirelli Francis X | Director | – | Jul 5, 2022 | 0 |
| Reeves Karen | Director | – | Jul 5, 2022 | 0 |
| Chiriva Internati Maurizio | CHIEF EXECUTIVE OFFICER | 1,378,072 | Sep 10, 2021 | 0 |
| Ryan Michael Charles | See Remarks | 50,189 | Aug 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 (view filing) | Sep 9 | 1 day | Chiriva Internati MaurizioCHIEF EXECUTIVE OFFICER | PPurchase | +2.80K | $3.70 | +$10.4K | +0.2%1.38M after | |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Ralston Shannon10% Owner | PPurchase | +800.0K | – | – | – | DerivativePrice outlier |
| Jun 12, 2024 (view filing) | Jun 11-12 | 1 day | Bersani PietroCEO | PPurchase | +6.00K | $3.26 | +$19.5K | +4.5%138.8K after | 2 lots |
| Jun 12, 2024 (view filing) | Jun 12 | Same day | Hungerford BrianCFO | PPurchase | +1.00K | $3.18 | +$3.18K | +1.8%57.9K after | |
| Jun 12, 2024 (view filing) | Jun 10 | 2 days | Misajon PamelaDirector | PPurchase | +1.70K | $2.93 | +$4.98K | +6.7%27.2K after | |
| Jun 12, 2024 (view filing) | Jun 11 | 1 day | Nagel MichaelDirector | PPurchase | +1.00K | $3.33 | +$3.33K | +2.4%43.3K after | |
| Jun 13, 2024 (view filing) | Jun 13 | Same day | Hungerford BrianCFO | PPurchase | +1.00K | $2.60 | +$2.60K | +1.7%58.9K after | |
| Jun 13, 2024 (view filing) | Jun 12 | 1 day | Misajon PamelaDirector | PPurchase | +1.61K | $3.28 | +$5.29K | +5.9%28.8K after | 2 lots |
| Aug 14, 2024 (view filing) | Aug 13 | 1 day | Hungerford BrianChief Financial Officer | PPurchase | +2.00K | $1.75 | +$3.50K | +3.4%60.9K after | |
| Aug 21, 2024 (view filing) | Aug 19-20 | 2 days | Hungerford BrianChief Financial Officer | PPurchase | +4.00K | $2.20 | +$8.81K | +6.6%64.9K after | 2 lots |
| Aug 26, 2024 (view filing) | Aug 23-26 | 3 days | Bersani PietroChief Executive Officer | PPurchase | +3.49K | $2.12 | +$7.41K | +2.5%142.3K after | 2 lots |